These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Analysis of aprotinin on the mean arterial pressure, carotid artery blood flow, and hindlimb vascular resistance in the live rat, and pulmonary vascular resistance in the isolated perfused rat lung. Jahr JS; Kaye AD; Kang B; Feng CJ; Nossaman BD J Med; 1995; 26(1-2):31-42. PubMed ID: 7561529 [TBL] [Abstract][Full Text] [Related]
9. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635 [TBL] [Abstract][Full Text] [Related]
12. Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate. Hua J; Sheng Y; Pinney KG; Garner CM; Kane RR; Prezioso JA; Pettit GR; Chaplin DJ; Edvardsen K Anticancer Res; 2003; 23(2B):1433-40. PubMed ID: 12820406 [TBL] [Abstract][Full Text] [Related]
13. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA; Welsh ME; Carter DE; Karlik SJ J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483 [TBL] [Abstract][Full Text] [Related]
14. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
15. Effects of BW245C, a prostaglandin dp receptor agonist, on systemic and regional haemodynamics in the anaesthetized rat. Koch KA; Wessale JL; Moreland R; Reinhart GA; Cox BF Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):931-5. PubMed ID: 16405449 [TBL] [Abstract][Full Text] [Related]
16. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine. Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377 [TBL] [Abstract][Full Text] [Related]
17. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats. Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016 [TBL] [Abstract][Full Text] [Related]
18. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. McDougall SR; Anderson AR; Chaplain MA; Sherratt JA Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model. Allison B; Yang Y; Pourrier M; Gibson JK J Cardiovasc Pharmacol; 2011 Apr; 57(4):463-8. PubMed ID: 21283020 [TBL] [Abstract][Full Text] [Related]
20. Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcoma. Bell KM; Prise VE; Chaplin DJ; Tozer GM Br J Cancer Suppl; 1996 Jul; 27():S161-3. PubMed ID: 8763871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]